Innovative Biopharmaceutical Compound Synthesis

Heparinex, L.L.C. is a biopharmaceutical company focused on the novel recombinant synthesis of compounds for markets including anticoagulation, inflammation, and cancer treatment areas. Leading carbohydrate chemist and glycobiologist Dr. Paul DeAngelis, originally discovered and patented Heparinex’s core technology platforms of proprietary carbohydrate production.


Contact Us

Heparinex L.L.C.

Business Operations:

c/o Emergent Technologies, Inc.
7500 Rialto Blvd., Bldg. 2 Ste. 260
Austin, TX 78735

Technical Contact:

Dr. Paul DeAngelis, Chief Scientist
Oklahoma City, OK USA 73104

Phone: (405) 271-2227 x61210

Copyright © 2019 Heparinex L.L.C. All rights reserved.

Website designed by RTL Digital Media